BioMarin Pharmaceutical Inc. 8-K Report: Key Updates & Insights

Based on the provided XML section of the financial report, here are the key details extracted:

1. Company Information:

• Name: BioMarin Pharmaceutical Inc.
• Location: 770 Lindaro Street, San Rafael, CA 94901.
• Contact: (415) 506-6700.
• CIK Number: 0001048477.
• SEC File Number: 000-26727.
• EIN: 68-0397820.
• Common Stock Par Value: $0.001.
• Ticker Symbol: BMRN (traded on NASDAQ).

2. Filing Details:

• Filing Type: 8-K (Current Report).
• Filing Date: February 20, 2025.

3. Reporting Period:

• Period Start Date: February 20, 2025.
• Period End Date: February 20, 2025 (indicating this may be a single-day event or disclosure).

4. XML and XBRL References:

• XML Version: 1.0
• XBRL Namespace: The report is structured using XBRL (eXtensible Business Reporting Language), which is commonly used for financial data reporting.

Insights:

• The filing indicates that BioMarin Pharmaceutical Inc. is providing a current report on February 20, 2025, which could relate to significant events such as acquisitions, changes in management, or other major corporate events that necessitate immediate disclosure to investors.
• The company is publicly traded, which means it is subject to SEC regulations and requirements for timely disclosures.
• The document's reference to a schema file ("bmrn-20250220.xsd") suggests structured data that can be analyzed for further financial details.

This section provides a foundational overview of the company and its recent filing, which can be important for investors and analysts following BioMarin Pharmaceutical Inc.